enVVeno Medical Corporation logo

enVVeno Medical Corporation

NVNO | NASDAQ
Chart Builder DCF Calculator
$9.05
+$0.08 (+0.84%)
At close: Sep 21, 2026, 4:00 PM ET
$9.05
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$148.11K
Enterprise Value
$-20.83M
Beta
1.07
Average Volume
15.5K
Shares Outstanding (Diluted)
671K
Shares Change YoY
3938.76%
Institutional Ownership
15.37%
Exchange
NASDAQ
ISIN
US29415J2050

Price Performance

Price Change 1M
-10.8%
Price Change 3M
-7.6%
Price Change 6M
-17.6%
Price Change YTD
-27.2%
Price Change 1Y
-72.4%
Price Change 3Y
-95.0%
Price Change 5Y
-97.4%
1M CAGR (ann.)
-11.5%
1Y CAGR (ann.)
-71.8%
5Y CAGR (ann.)
-50.7%
All-Time CAGR
-52.9%

Valuation

PE Ratio
-0.02
Forward PE
N/A
PEG Ratio
-0.00
Forward PEG
0.00
PS Ratio
N/A
Forward PS
0.00
PB Ratio
0.01
P/FCF Ratio
-0.01
P/Adj. FCF Ratio
-0.01
P/OCF Ratio
-0.42
EV/Sales
N/A
EV/EBIT
1.31
EV/EBITDA
1.34
EV/FCF
1.42
Earnings Yield
-5746.7%
FCF Yield
-9790.3%
Adj. FCF Yield
-11256.0%

Financial Health

Net Cash
$21.49M
Total Debt
$505K
Cash & Short-Term Investments
$21.49M
Total Assets
$22.66M
Current Ratio
11.70
Quick Ratio
11.70
Debt / Equity Ratio
0.02
Debt / EBITDA
-0.03
Debt / FCF
-0.03
OCF / Debt
-28.95
Interest Coverage
0.00
Altman Z-Score
-12.25
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-15.0%

Returns

Return on Assets
-69.4%
Return on Equity
-62.3%
Return on Invested Capital
-79.1%
Return on Capital Employed
-80.7%
Return on Tangible Assets
-69.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
-49.4%
EPS CAGR 3Y
51.1%
EPS CAGR 5Y
30.2%
EPS CAGR 10Y
33.4%
FCF CAGR 3Y
6.3%
FCF CAGR 5Y
-1.6%
FCF CAGR 10Y
-14.9%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-14.62M
Free Cash Flow
$-14.62M
Adj. Free Cash Flow
$-16.81M
FCF Per Share
-$21.79
OCF Per Share
-$21.79
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-237K
Operating Income
$-16.75M
EBITDA
$-15.58M
Net Income
$-15.72M
EPS (Diluted)
-$520.08
Revenue / Employee
N/A
Profit / Employee
$-476.48K
Employees
33

© 2026 bestshares.com. All rights reserved.